Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Antibe Therapeutics Inc (ATE.TO)

Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Antibe Therapeutics Inc. Baystreet - Thu Feb 1, 9:12AM CST

Is extending the Early Warrant Exercise Incentive Program for its 6.4 million outstanding and unlisted ...

ATE.TO : 0.2950 (+13.46%)
Stocks in play: Antibe Therapeutics Inc. Baystreet - Tue Dec 12, 2023

Announces that it is extending the expiry date and amending the exercise price of the common share purchase ...

ATE.TO : 0.2950 (+13.46%)
Stocks in play: Antibe Therapeutics Inc. Baystreet - Wed Nov 1, 2023

Announced the completion of the pharmacokinetic/pharmacodynamic study of otenaproxesul’s faster-absorbing ...

ATE.TO : 0.2950 (+13.46%)
Stocks in play: Antibe Therapeutics Inc Baystreet - Wed Oct 18, 2023

Announced the initiation of the pharmacokinetic/pharmacodynamic study of otenaproxesul’s faster-absorbing ...

ATE.TO : 0.2950 (+13.46%)
Stocks in play: Antibe Therapeutics Inc. Baystreet - Thu Sep 28, 2023

Announced Health Canada’s approval to initiate the pharmacokinetic/pharmacodynamic study of otenaproxesul’s ...

ATE.TO : 0.2950 (+13.46%)
Toronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite PR Newswire - Mon Aug 21, 2023

/PRNewswire/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE) shares his Company's story in an interview with TMX Group....

ATE.TO : 0.2950 (+13.46%)
Toronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite Newswire.ca - Mon Aug 21, 2023

/CNW/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE) shares his Company's story in an interview with TMX Group. The...

ATE.TO : 0.2950 (+13.46%)
Antibe’s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit Business Wire - Tue Apr 25, 2023

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its...

ATE.TO : 0.2950 (+13.46%)
ATBPF : 0.2156 (+13.47%)
Antibe to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Business Wire - Tue Apr 18, 2023

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its...

ATE.TO : 0.2950 (+13.46%)
ATBPF : 0.2156 (+13.47%)
Stocks in play: Antibe Therapeutics Inc. Baystreet - Tue Apr 11, 2023

Provided a corporate update. Further to Antibe’s update of February 15, 2023, the Company has now selected ...

ATE.TO : 0.2950 (+13.46%)

Barchart Exclusives

Should You Follow Insider Buying On This High-Yield REIT? Barchart - Wed May 22, 6:30PM CDT
A director at Public Storage recently made a hefty investment in the company's stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot